Treatment of moderate to severe pediatric asthma: Omalizumab and potential future use of monoclonal antibodies (Q37062124)

From Wikidata
Jump to navigation Jump to search
scientific article published on July 2016
edit
Language Label Description Also known as
English
Treatment of moderate to severe pediatric asthma: Omalizumab and potential future use of monoclonal antibodies
scientific article published on July 2016

    Statements

    Treatment of moderate to severe pediatric asthma: Omalizumab and potential future use of monoclonal antibodies (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit